[Federal Register Volume 68, Number 150 (Tuesday, August 5, 2003)]
[Notices]
[Page 46227]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-19812]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturers of Controlled Substances; Notice of Registration

    By Notice dated March 14, 2003, and published in the Federal 
Register on April 2, 2003, (68 FR 16091) Rhodes Technologies, 498 
Washington Street, Coventry, Rhode Island 02816, made application by 
renewal to the Drug Enforcement Administration to be registered as a 
bulk manufacturer of the basic classes of Schedule I and II controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Methylphenidate (1724).....................  II
Codeine (9050).............................  II
Dihydrocodeine (9102)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Thebaine (9333)............................  II
Noroxymorphone (9668)......................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to produce bulk products for conversion and 
distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Rhodes Technologies to manufacture 
the listed controlled substances is consistent with the public interest 
at this time. DEA has investigated Rhodes Technologies to ensure that 
the company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed is granted.

    Dated: July 22, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-19812 Filed 8-4-03; 8:45 am]
BILLING CODE 4410-09-M